Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., Lawrenceville, GA 30046, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788, NDC 76282-405-05.
Published May 27, 2020 · Recall initiated: May 14, 2020
Summary
FDA records drug Class III recall D-1272-2020, published May 27, 2020 and initiated May 14, 2020. Recalling firm: InvaGen Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 2,202 bottles; Lot: Lot # NB900413, Exp. 12/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if GABAPENTIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GABAPENTIN
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- Distributor
- Nationwide in the U.S.
- UPC
- 0376282405902
- Lot
- Lot # NB900413, Exp. 12/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by:October 29, 2025
- FDAGabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by:October 29, 2025
- FDAGabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged andJuly 9, 2025
- FDAGabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJORJuly 9, 2025
- FDAAloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: MylanMay 27, 2020
- FDAEthacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward PharmaceuticalsMay 27, 2020
Questions about this recall
Was Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., Lawrenceville, GA 30046, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788, NDC 76282-405-05. recalled?
Yes. FDA published recall D-1272-2020 on May 27, 2020. Reported hazard: Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GABAPENTIN. UPC: 0376282405902.